Dutasteride/Tadalafil

度他雄胺/他达拉非

Report date: 2025/12/03 10:09:52

Base Information

Drug NameDutasteride/Tadalafil
Drug Alias NameTadalafil/dutasteride他达拉非+度他雄胺度他雄胺+他达拉非Tadalafil+dutasterideDutasteride+tadalafil +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionPhosphodiesterase 5A inhibitorsSteroid 5 alpha reductase inhibitors
TargetsSteroid 5 alpha reductasePhosphodiesterase 5A
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2025/01/23
Country/TerritorySouth Korea
CombinationsYes TadalafilDutasteride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDongkook
China Registration ClassN/A

Develop Information

Active CompaniesDong Kook Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A